Lyka Labs Limited has informed the Exchange regarding a press release dated April 08, 2025, titled "Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the LODR) Pursuant to the Regulation 30 and other applicable provisions of the LODR, we are pleased to inform you that Company has been granted a patent for Indian Patent for its proprietary product, Pregabalin Gel 8% by Patent Office India. ".